NPC @ Academy of Managed Care Pharmacy Annual Meeting 2019

March 25-28, 2019
San Diego, California

The 2019 Academy of Managed Care Pharmacy Annual Meeting will be held on March 25-28 in San Diego, California. NPC Vice President of Comparative Effectiveness Research Jennifer Graff, PharmD, will address “Patient-Reported Outcomes and Patient Preferences: Considerations for Coverage Policy Decisions?” on March 26 at 4:30 p.m. In addition, two posters on patient access to medication based on research co-authored by NPC will be presented on Wednesday, March 27, at 11:30 a.m. 

Agenda

Panels

[R3] Patient-Reported Outcomes and Patient Preferences: Considerations for Coverage Policy Decisions?

Tuesday, March 26, 4:15 p.m.-5:30 p.m.

Globally, health plans and payers are expanding their efforts to solicit patient and public input when allocating health resources. However, despite the increased availability of patient-reported outcomes and consumer cost-sharing data, it is unclear how patient or health plan member input is considered by health plans when making coverage decisions. Concerns exist that patient-input may disrupt the contractual requirements for health plans to provide “medically necessary” care and treatments. Additionally, allocation of resources may be inefficient if the treatments reimbursed for care are not valued by the patients who will ultimately use the services. 

This session and panel discussion will focus on the following key questions: What types of input should be considered (e.g., consultation, deliberation, etc.)? When should input be solicited (e.g., before, during or after the coverage decision)? What input should be considered (e.g., published patient-reported outcomes, lay-patients, member surveys, etc.)? Whose input matters (e.g., members, patient group, etc.)? What are the barriers and opportunities? 

At the completion of this activity, participants should be able to:

  1. Describe how health plans currently consider patient input (e.g., member input, patient preference, and patient-reported outcomes) when developing specialty drug coverage policies.
  2. Contrast procedures to solicit and incorporate patient input with procedures to solicit and incorporate provider input in coverage policies.
  3. Deliberate the importance of patient input in coverage development.
  4. Summarize the challenges and opportunities associated with incorporating patient input and patient-reported outcomes in coverage policies.

Speakers:

  • Jennifer S. Graff, PharmD (Moderator), Vice President of Comparative Effectiveness Research, National Pharmaceutical Council
  • Kim A. Caldwell, RPh, Principal, Texas Star Healthcare Consulting, LLC
  • James D. Chambers, PhD, MPharm, MSc, Associate Professor, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
  • Eleanor M. Perfetto, PhD, Executive Vice President, Strategic Initiatives, National Health Council

Poster Presentations

Interventions impacting medication access: A scoping review

On display: Tuesday, March 26, 5:30-7:30 p.m.

Poster presentation: Wednesday, March 27, 11:30 a.m.-1 p.m.

Redefining Medication Access: Designing a Conceptual Framework to Advance Quality Measurement

On display: Tuesday, March 26, 5:30-7:30 p.m.

Poster presentation: Wednesday, March 27, 11:30 a.m.-1 p.m.